Cubist Pharma Cash Flow - Annual (NASDAQ:CBST)

Add to My Stocks
$101.94 $0.14 (0.14%) CBST stock closing price Jan 21, 2015 (Closing)

The Cubist Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. While its important to look at the Cubist Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Cubist Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Cubist Pharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Cubist Pharma had cash and cash equivalents of $104.04M at the beginning of the year and $91.05M at year end for 2013. Cubist Pharma has a negative cash and cash equivalents change of $-12.98M.

View details of Cubist Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow77.32M61.3M40.24M35.77M27.03M10.71M
Net Increase (Decrease) in Assets Liabilities-29.22M35.32M23.98M-11.12M-1.16M5.51M
Cash From (used in) Discontinued Operations------
Other Adjustments Net-13.12M-35.05M103.11M65.5M55.11M-63.85M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-15.5M-18.12M-100.06M-17.47M-11.1M-25.33M
Acquisition Disposition of Subsidiaires-1.21B--200.65M--92.17M-10.19M
Increase (Decrease) in Investments458.88M-214.28M-138.81M-205.22M-313.74M-
Other Cash Inflow (Outflow) from Investment Activities-20M-----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares160.74M36.12M61.55M16.33M4.74M14.42M
Issuance (Repayment) of Debt Securities620.61M-109.21M-259.21M--46.84M
Increase (Decrease) in Bank & Other Borrowings------
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities-23.19M-3.71M1.28M-22.56M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-----0.23M-0.01M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year104.04M197.61M372.96M157.31M409.02M354.78M
Cash & Equivalents at Year End91.05M104.04M197.61M372.96M157.31M409.02M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Cubist Pharma stock price history provides insight into historical stock price fluctuations, and Cubist Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Cubist Pharma saw a positive change in Net Change in Cash and Cash Equivalents of $-12.98M in 2013. Apart from the Cubist Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $16.4M for CBST.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-787.62M for CBST stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Cubist Pharma and its owners and creditors and was $758.16M for 2013. Financing activities allow a company to raise capital, and repay bondholders.

Annual Cash Flow Statements For Cubist Pharmaceuticals Inc Peers

AMNEAL PHARMACT cash flow, Jazz Pharma cash flow, Receptos cash flow